Drawing for BREYNA

USPTO serial 88634036

BREYNA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LEE, DOUGLAS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BREYNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema; Anti-inflammatoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 11, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 11, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 10, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2023EX5GSOU EXTENSION 5 GRANTED—
Feb 6, 2023EXT5SOU EXTENSION 5 FILED—
Feb 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 25, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 24, 2022EX4GSOU EXTENSION 4 GRANTED—
Aug 9, 2022IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Aug 9, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2022INCEITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST—
Aug 3, 2022EXT4SOU EXTENSION 4 FILED—
Aug 3, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 24, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 23, 2022EX3GSOU EXTENSION 3 GRANTED—
Mar 23, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 14, 2022NREVNOTICE OF REVIVAL - E-MAILED—
Feb 14, 2022TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Feb 14, 2022PETGPETITION TO REVIVE-GRANTED—
Feb 14, 2022PROATEAS PETITION TO REVIVE RECEIVED—
Feb 11, 2022EXT3SOU EXTENSION 3 FILED—
Nov 18, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 18, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 18, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 12, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 10, 2021EX2GSOU EXTENSION 2 GRANTED—
Aug 10, 2021EXT2SOU EXTENSION 2 FILED—
Aug 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 10, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 10, 2021EXT1SOU EXTENSION 1 FILED—
Feb 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 28, 2020ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 26, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 13, 2020ALIEASSIGNED TO LIE—
Jan 3, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 2, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 2, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 2, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 2, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 31, 2019DOCKASSIGNED TO EXAMINER—
Oct 2, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance